Ann: Positive AD-214 Phase I extension study results, page-171

First 171 Last

Share
Profile

Follow
Beno77

5,354 Posts.

654

26/03/24

10:43

Post #: 73058668
Share

Originally posted by waynesworld: ↑

for an upfront payment of $45m big pharma can save themselves not only the cost of developing the drug ($45m to date), but also the 7 years of development @rlj

The MD has said that its time to realise the value of the investment in AD-214. So, what is the value of that investment to date? For a biotech located in the US, one might conservatively imagine that getting a drug candidate in readiness for Phase 2 would be north of US$100m. According to the balance sheet for AdAlta as at 31 Dec 2023, it appears that the figure - as represented by accumulated losses - is AUD$45m.

By chance, IPF assets - according to the Gems presentation - command upfront license payments of more than US$45m. Neat numerical symmetry. Lets call the currency difference between USD and AUD as the initial return on investment, following the recoupment of investment to date.

I know its just playing with numbers but its kind of funny how the answer between the company balance sheet and the corporate presentation is 45. Its close enough to another well known number so lets call it the Hitchhikers Guide to Investment Return.

Expand

Mate they are asking for a “minimum “ of US $45m and that’s has nothing to do with what’s spent to get to here it is because of previous deals being made. Every chance deal could come on far higher than that.

1AD Price at posting: 2.6¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

KOB

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

MGU

New results confirm Buena Vista's iron grades potential

MYE

Grosvenor mine fire takes another scalp as Metarock's 168-person presence on-site suspended by Anglo

MRC

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

There are more pages in this discussion • 92 more messages in this thread...

First 171 Last

Add 1AD (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $14.89M

Open	High	Low	Value	Volume
2.5¢	2.5¢	2.5¢	$8.701K	348.0K

Buyers (Bids)

No.	Vol.	Price($)
3	174960	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	399948	2

View Market Depth

No.	Vol.	Price($)
3	174960	0.024
2	408381	0.023
2	90904	0.022
2	1047615	0.021
4	626841	0.020

Price($)	Vol.	No.
0.025	99948	1
0.026	400000	2
0.027	217643	2
0.028	125208	3
0.029	3041	1

Last trade - 13.28pm 31/07/2024 (20 minute delay)

1AD (ASX) Chart

Ann: Positive AD-214 Phase I extension study results, page-171

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

New results confirm Buena Vista's iron grades potential

Grosvenor mine fire takes another scalp as Metarock's 168-person presence on-site suspended by Anglo

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive AD-214 Phase I extension study results, page-171

Top Stories

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

New results confirm Buena Vista's iron grades potential

Grosvenor mine fire takes another scalp as Metarock's 168-person presence on-site suspended by Anglo

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News